[Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma

Hua Li1, Xin-lu Wang, Yang Yang

  • 1Liver Transplantation Center, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. lihua100@yeah.net

Abstract

Insights

This study demonstrates that small interfering RNA (siRNA) targeting human telomerase reverse transcriptase (hTERT) effectively suppresses hepatocellular carcinoma cell proliferation and activity. The developed retroviral vector successfully reduced telomerase activity and induced apoptosis in HepG2 cells.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Therapy

Context:

  • Hepatocellular carcinoma (HCC) is a significant global health concern with limited treatment options.
  • Human telomerase reverse transcriptase (hTERT) is a key enzyme in telomere maintenance, often overexpressed in cancer cells, contributing to uncontrolled proliferation.
  • Targeting hTERT presents a promising strategy for inhibiting cancer cell growth and inducing apoptosis.

Purpose:

  • To construct a recombinant retroviral vector (pLXSN-EGFP-U6-siTERT) for delivering small interfering RNA (siRNA) against hTERT.
  • To evaluate the efficacy of this vector in inhibiting telomerase activity, inducing apoptosis, and suppressing proliferation in human hepatocellular carcinoma (HepG2) cells.

Summary:

  • The recombinant retroviral vector pLXSN-EGFP-U6-siTERT was successfully constructed and sequence-verified.
  • Infection of HepG2 cells with the vector led to significant reductions in telomerase activity (up to 85.01% at 72 hours) and a notable increase in apoptosis rate (29.05% at 24 hours).
  • MTT assays confirmed marked inhibition of HepG2 cell proliferation compared to control groups.

Impact:

  • This research validates the potential of hTERT siRNA delivered via a retroviral vector as a therapeutic strategy for hepatocellular carcinoma.
  • The findings suggest that silencing hTERT can effectively control cancer cell proliferation and promote cell death, offering a new avenue for HCC treatment.
  • Further investigation into this gene-silencing approach could lead to novel targeted therapies for various cancers characterized by hTERT overexpression.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...